Cagrilintide CGL5 CGL10 1415456-99-3 safe delivery quickly high purity peptide
6 Inquiries
1415456-99-3
Pharmaceutical Grade
99%
sh
JL
box
Yes
2028-08-31
Peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Basic Info-
Product Name:
Cagrilintide
Other Name:Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide
CAS No.:1415456-99-3
Molecular Formula:C194H312N54O59S2
Molecular Weight:0
EC Number:206-141-6
Color/Form:White to off-white
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide
-
Location:
zhejiangshengjinhuashiyiwushijiangdongjiedaodongnanlu656hao
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History6 Inquiries
Country Product Purchase Quantity Date Posted
United States
Cagrilintide
20 MG Sep 30, 2026
Peru
Cagrilintide 20MG vial
10 PCS Jul 10, 2026
United States
Cagrilintide
1 G May 18, 2026
United States
Tirzepatide
50 MT Apr 2, 2026
Thailand
Carglitide
10 MG Sep 9, 2024
United States
TR
100 G May 1, 2026 Post an enquiry for this product
More from this Seller
-
-
-
--High-quality SHB products: factory-direct sales, bulk supply, competitive pricing, direct shipping, and reliable quality.
Pharmaceutical Grade / 99%
$1/KG FOB
-
-
-
-
Vesugen VE20 Pharmaceutical Grade Lyophilized Powder safe delicery high purity
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
Advanced Peptide Selank Mt2 Dsip Epithalon Adipotide Semax Ss31 Fast Delivery AP5
Pharmaceutical Grade / 99%
$33-34/UNIT FOB
-
-
-
-
Ahkcu 99% Purity, High purity, available in stock, factory direct sales
Pharmaceutical Grade / 99%
$6-7/UNIT FOB
-
-
-
-
Survodutide high purity 99% safe delivery lyophilized powder pharmaceutical grade
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
Crystagen 99%Freeze-dried powder In stock Minimum Order Hot Selling 334-50-9
Pharmaceutical Grade / 99%
$33-36/UNIT FOB
-